VITREOMACULAR TRACTION AFTER DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX) INJECTION: THE EFFECT OF ANOMALOUS POSTERIOR VITREOUS DETACHMENT

Retin Cases Brief Rep. 2016 Winter;10(1):55-7. doi: 10.1097/ICB.0000000000000172.

Abstract

Purpose: To describe an unusual macular complication after dexamethasone intravitreal implant (Ozurdex) injection.

Methods: Case history and macular optical coherence tomography findings are described. The report describes a patient with proliferative diabetic retinopathy and vitreoschisis who received Ozurdex treatment for diabetic macular edema.

Results: After Ozurdex injection, visual acuity worsened because of newly formed vitreomacular traction that was demonstrated on optical coherence tomography imaging. A mechanism is proposed by which the medication might have contributed to this outcome.

Conclusion: In this patient with vitreoschisis, a thickened posterior hyaloid membrane and traction developed after Ozurdex injection. The authors recommend careful evaluation of the macula before injection, particularly in diabetic patients with vitreoschisis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / adverse effects*
  • Dexamethasone / adverse effects*
  • Drug Implants / adverse effects*
  • Humans
  • Intravitreal Injections
  • Male
  • Retinal Detachment / chemically induced*
  • Vitreous Detachment / chemically induced*

Substances

  • Anti-Inflammatory Agents
  • Drug Implants
  • Dexamethasone